TY - JOUR KW - Adolescent KW - Adult KW - Aged KW - Antibodies, Bacterial KW - Data Interpretation, Statistical KW - Erythema Nodosum KW - Female KW - Humans KW - Immunoglobulin G KW - Immunoglobulin M KW - Interferon-gamma KW - Leprostatic Agents KW - Leprosy, Borderline KW - Leprosy, lepromatous KW - Leprosy, Tuberculoid KW - Male KW - Middle Aged KW - Mycobacterium leprae KW - Thalidomide KW - Tumor Necrosis Factor-alpha AU - Partida-Sanchez S AU - Favila-Castillo L AU - Pedraza-Sanchez S AU - Gomez-Melgar M AU - Saúl A AU - Estrada-Parra S AU - Estrada-Garcia I AB -

A group of 9 Mexican lepromatous leprosy patients was studied at the beginning of a type II reaction (erythema nodosum leprosum, ENL) and after 1 or 2 months of thalidomide treatment. ENL patients at the onset of the reaction had slightly higher amounts of anti-Mycobacterium leprae IgG1 and IgG2 antibodies, compared to similar lepromatous patients that did not develop ENL. Neither these antibody levels nor IgM and the other IgG subclasses were importantly modified after thalidomide treatment. Serum TNF was significantly higher in the patients that developed ENL compared to those that did not develop the reaction. TNF levels were slightly decreased after 1 month of thalidomide treatment and significantly decreased after 2 months of treatment. Serum IFN-gamma was significantly lower in patients at the onset of ENL and was increased after 1 and 2 months of thalidomide treatment.

BT - International archives of allergy and immunology C1 - http://www.ncbi.nlm.nih.gov/pubmed/9623511?dopt=Abstract DA - 1998 May DO - 10.1159/000023926 IS - 1 J2 - Int. Arch. Allergy Immunol. LA - eng N2 -

A group of 9 Mexican lepromatous leprosy patients was studied at the beginning of a type II reaction (erythema nodosum leprosum, ENL) and after 1 or 2 months of thalidomide treatment. ENL patients at the onset of the reaction had slightly higher amounts of anti-Mycobacterium leprae IgG1 and IgG2 antibodies, compared to similar lepromatous patients that did not develop ENL. Neither these antibody levels nor IgM and the other IgG subclasses were importantly modified after thalidomide treatment. Serum TNF was significantly higher in the patients that developed ENL compared to those that did not develop the reaction. TNF levels were slightly decreased after 1 month of thalidomide treatment and significantly decreased after 2 months of treatment. Serum IFN-gamma was significantly lower in patients at the onset of ENL and was increased after 1 and 2 months of thalidomide treatment.

PY - 1998 SP - 60 EP - 6 T2 - International archives of allergy and immunology TI - IgG antibody subclasses, tumor necrosis factor and IFN-gamma levels in patients with type II lepra reaction on thalidomide treatment. UR - http://academia.edu/2039784/lgG_subclasses_antibodies_TNF_IFN-gamma_levels_in_patients_with_type-II_lepra_reaction_under_thalidomide_treatment VL - 116 SN - 1018-2438 ER -